Skip to main content
TipRanks
Go Ultimate75% OFF

Predictmedix (QAI) AI Stock Analysis

8 Followers
TSE:QAI

Predictmedix

(CNQX:QAI)

Select Model
Rating:39Underperform
Price Target:CAD 0.05â–²(160.00% Upside)
Action:downgraded
Date:02/28/26

Critical financial distress with zero revenue, losses, negative equity, and cash burn dominate; neutral technicals and poor valuation due to negative P/E reinforce high risk.

Positive Factors
Low reported debtNear-zero reported debt provides structural financial flexibility relative to highly leveraged peers. Over the next 2–6 months this reduces insolvency risk, eases interest burdens, and increases optionality to raise capital or invest in product development without heavy fixed financing costs.
Negative Factors
Negative shareholders' equityDeeply negative equity reflects cumulative losses and materially weakens the balance sheet. Over months this limits financial flexibility, can impair counterparty confidence, restricts access to traditional financing, and raises the likelihood of dilutive recapitalizations if revenues don't stabilize.

Predictmedix (QAI) vs. iShares MSCI Canada ETF (EWC)

-80%-60%-40%-20%0%20%40%TSE:QAI-75.00%EWC+8.99%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CAD 4.25M
Dividend Yield
―
Average Volume (3M)
89.71K
Price to Earnings (P/E)
-9.1
Beta (1Y)
1.89
Revenue Growth
―
EPS Growth
23.08%
Country
Canada
Employees
0
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

Predictmedix Business Overview & Revenue Model

Company Description

Predictmedix Inc., an artificial intelligence (AI) company, develops AI powered technologies for general workplace health and safety, and health care industry. The company operates in two segments, Workplace Health and Safety, and Healthcare. It offe...

How the Company Makes Money

null

Predictmedix Financial Statement Overview

Summary

Zero revenue, widening net losses to -$1.2M, negative gross profit, deeply negative equity at -$1.3M, and persistent cash burn reflect severe distress and high insolvency risk despite zero debt.

Income Statement

5Very Negative

Balance Sheet

15Very Negative

Cash Flow

10Very Negative
Financial statement breakdown
BreakdownTTMApr 2025Jan 2024Apr 2023Apr 2022Apr 2021
Income Statement
Total Revenue00035.02K134.82K0
Gross Profit-53.55K-155.31K-167.63K26.62K84.82K-3,509
EBITDA-849.06K-788.14K-1.82M-1.91M-1.80M-1.93M
Net Income-1.18M-1.18M-1.99M-2.07M-1.88M-1.93M
Balance Sheet
Total Assets485.90K131.95K481.33K717.74K1.24M1.00M
Cash, Cash Equivalents and Short-Term Investments313.74K036.87K79.25K211.30K480.05K
Total Debt00037.87K015.19K
Total Liabilities1.29M1.45M625.14K871.12K349.67K135.35K
Stockholders Equity-799.49K-1.32M-143.82K-153.39K886.99K868.29K
Cash Flow
Free Cash Flow-761.17K-36.87K-1.64M-678.85K-1.95M-1.27M
Operating Cash Flow-761.17K-36.87K-1.64M-534.17K-1.53M-1.08M
Investing Cash Flow000-144.68K-418.12K-195.01K
Financing Cash Flow1.07M01.60M546.80K1.68M261.12K

Predictmedix Technical Analysis

Technical Analysis SentimentNegative
Last Price0.02

Price Trends

50DMA0.03Negative
100DMA0.03Negative
200DMA0.04Negative

Market Momentum

MACD0.00Positive
RSI40.43Neutral
STOCH33.33Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:QAI, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.03, and below the 200-day MA of 0.04, indicating a bearish trend. The MACD of 0.00 indicates Positive momentum. The RSI at 40.43 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:QAI.

Predictmedix Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

TSE:QAI against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:BLOTSE:BLO46NeutralCAD 45.58M-11.15-232.36%――-84.43%
TSE:PINKTSE:PINK43NeutralCAD 20.71M-1.03-303.05%―35.27%58.34%
TSE:QAITSE:QAI39UnderperformCAD 4.60M-9.06123.63%――23.08%
TSE:VPTTSE:VPT39UnderperformCAD 13.50M-4.9856.40%―89.06%37.62%

* Healthcare Sector Average

Performance Comparison

0%100%200%TSE:QAITSE:PINKTSE:VPTTSE:BLODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TSE:QAI and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:QAIPredictmedix, Inc.0.02-0.05-71.43%
TSE:PINKPerimeter Medical Imaging Ai Inc0.14-0.04-25.00%
TSE:VPTVentriPoint Diagnostics0.07-0.02-27.78%
TSE:BLOCannabix0.37-0.18-32.73%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Feb 28, 2026